| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 324,509 | 243,634 | 228,574 | 217,032 | | Cost of Revenue | 208,592 | 161,431 | 161,519 | 164,859 | | | Gross Profit | 115,917 | 82,203 | 67,055 | 52,173 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,478 | 5,959 | 5,686 | 4,367 | | Non Recurring |
-
| (61) | (228) |
-
| | Others | 28,836 | 26,832 | 25,963 | 24,002 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 79,603 | 49,473 | 35,634 | 23,804 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,569 | 4,058 | 6,921 | (6,179) | | Earnings Before Interest And Taxes | 87,038 | 50,911 | 42,957 | 18,300 | | Interest Expense | 18,602 | 18,166 | 17,475 | 19,990 | | Income Before Tax | 68,436 | 32,745 | 25,482 | (1,690) | | Income Tax Expense | 13,730 | 5,174 | 6,796 | (9,135) | | Minority Interest | (228) | 102 |
-
|
-
| | | | Net Income From Continuing Ops | 54,478 | 27,673 | 18,686 | 7,445 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 54,478 | 27,673 | 18,686 | 7,445 | | Preferred Stock And Other Adjustments |
-
| (198) | 198 |
-
| | | Net Income Applicable To Common Shares | $54,478 | $27,475 | $18,884 | $7,445 |
|
0.51% Nasdaq 
Income Statement
